title: Successful conservative management of campylobacter cholecystitis occurring post chemotherapy and rituximab: a rare disease entity.
abstract: Campylobacter jejuni is commonly associated with gastroenteritis, but extremely few reports worldwide link it acute cholecystitis. These infectious complications can assume menacing proportions in the immunocompromised and need careful management. We present a report of such a case from Australia, successfully managed conservatively, without surgery.
authors.affiliation: Department of Medical Oncology, Asian Cancer Center and Ex Consultant, Medical Oncology, Hervey Bay, Queensland, Australia. ajayajaygupta2002@rediffmail.com.
authors.forename: Ajay
authors.initials: A
authors.lastname: Gupta
authors.forename: Louise
authors.initials: L
authors.lastname: Tse
mesh_terms: D000368:Aged; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects*; D002169:Campylobacter Infections / Q000139:chemically induced / Q000150:complications*; D016123:Campylobacter jejuni; D002764:Cholecystitis / Q000382:microbiology / Q000628:therapy*; D003520:Cyclophosphamide / Q000008:administration & dosage; D005440:Fluid Therapy; D006801:Humans; D008228:Lymphoma, Non-Hodgkin / Q000188:drug therapy; D008297:Male; D011239:Prednisolone / Q000008:administration & dosage; D000069283:Rituximab / Q000008:administration & dosage; D014750:Vincristine / Q000008:administration & dosage
chemical_list: D000900:Anti-Bacterial Agents; D000069283:Rituximab; D014750:Vincristine; D003520:Cyclophosphamide; D011239:Prednisolone